Cargando…
Intermittent and episode-driven use of pranlukast to reduce the frequency of wheezing in atopic children: a randomized, double-blind, placebo-controlled trial
BACKGROUND: Leukotriene receptor antagonist (LTRA) therapy reduces asthma exacerbations in children older than 2 years. However, whether early intervention using LTRA in atopic smaller children aged 1 to 2 years who had experienced episodic wheezing can reduce the frequency of wheezing is unknown. M...
Autores principales: | Ebisawa, Motohiro, Terada, Akihiko, Sato, Kazuki, Kurosaka, Fumitake, Kondo, Naomi, Sugizaki, Chizuko, Morikawa, Akihiro, Nishima, Sankei, Urashima, Mitsuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382836/ https://www.ncbi.nlm.nih.gov/pubmed/25866598 http://dx.doi.org/10.1186/s40413-015-0062-3 |
Ejemplares similares
-
436 Ten Years Follow up of Japanese Survey on Immediate Type Food Allergy
por: Imai, Takanori, et al.
Publicado: (2012) -
492 Nationwide Survey of Immediate Type Food Allergy in Japan
por: Imai, Takanori, et al.
Publicado: (2012) -
Hospital oral food challenge tests in the coronavirus disease 2019 pandemic: A nationwide survey
por: Yanagida, Noriyuki, et al.
Publicado: (2023) -
Metabolite Dysregulation by Pranlukast in Mycobacterium tuberculosis
por: Yelamanchi, Soujanya D., et al.
Publicado: (2022) -
Efficacy and Safety of Modified Pranlukast (Prakanon(®)) Compared with Pranlukast (Onon(®)): A Randomized, Open-Label, Crossover Study
por: Kim, Seo W., et al.
Publicado: (2016)